semaglutide atrial fibrillation and AFib: Heart Safety for Weight Loss Effects of Glucagon-Like Peptide-1 Receptor

The dosing problem Microdosing assumes that anti-inflammatory effects occur at lower doses than metabolic effects

Retatrutide has been predominantly developed for weight loss for people with obesity and is proving promising (1)

Stopping medication removes the therapeutic effect while leaving the underlying condition in place

Join Trial Testing New Drug for Weight Management A clinical trial is recruiting adults with type 2 diabetes to test a new long-lasting amylin drug for weight management.

The long-term safety data extends over decades in the epilepsy community, where keto has been a standard treatment since the 1920s